Dr. Casey Paleos
Casey Paleos, MD is a psychiatrist and researcher with over a decade of experience in the use of psychedelic medicines for the treatment of mental illness, dating back to his work, while still in residency training, as a study therapist in the landmark Psilocybin Cancer Anxiety Study at NYU, where Dr. Guss was one of his mentors. Since then, Dr. Paleos was Co-Principal Investigator in the NYU-Bellevue Ketamine for Depression Study and has been treating patients in his private practice with both ketamine infusion therapy and ketamine-assisted psychotherapy since 2016. Presently, he is a study therapist and Principal Investigator, alongside Dr. Gorman, in the MAPS-sponsored MDMA-Assisted Psychotherapy for PTSD Phase 3 Clinical Trial, serves as Scientific Director at Mindbloom, Inc., and is a co-founder of Nautilus Sanctuary, a non-profit psychedelic research and clinical institution based in New York City.
Dr. Lawrence Fischman
Lawrence Fischman, MD, is a psychiatrist and psychoanalyst, who has practiced in New York and Maine for 36 years. In addition to his full-time private practice in New York, he was a Clinical Instructor in Psychiatry at New York-Presbyterian/ Weill Cornell Medical Center. In 1996, he moved to Maine, and became a Clinical Instructor in Psychiatry at Tufts University School of Medicine Maine Track, where he also serves on the Admissions subcommittee. In 1983, he published a paper comparing psychedelic drug states with dreams and psychosis in Schizophrenia Bulletin. In 2019, inspired by the renaissance in psychedelic research, he published a paper in Neuropsychoanalysis on psychedelic-assisted psychotherapy. He has enjoyed living, working and raising a family in Maine, and is excited by the emerging possibilities for integrating psychedelic experiences with psychoanalytically-based psychotherapy.
Brad Burge, MA
Director of Communications
Brad Burge earned his B.A. in Communication and Psychology from Stanford University in 2005 and his M.A. in Communication from the University of California, San Diego in 2009. He directed communications and public relations for the non-profit MAPS from 2009 to 2020, helping it scale from a small advocacy organization to a global leader in psychedelic pharmaceutical development. In 2020, Brad founded Integration Communications, which provides industry-leading PR, media relations, and education services in psychedelic science, therapy, health, and wellness. Brad is also a certified Wilderness First Responder, and when he’s not plugged in, you’ll find him in the mountains, carrying a backpack, somewhere down a long trail.
Interim Integration Certificate Program Director
Dr. Camargo is a psychologist based in New York City and maintains a private practice in Manhattan. His work is heavily influenced by psychoanalytic and attachment theories where he works with clients to address anxiety, depression, life transitions and spiritual crises. In addition, he provides psychedelic harm reduction and integration, helping clients prepare for psychedelic experiences, incorporate insights or cope with challenges post-experience. He also trained as a psilocybin therapist through Compass Pathways and serves as a therapist on an investigator-initiated clinical trial of psilocybin for Body Dysmorphic Disorder at New York Psychiatric Institute. Dr. Camargo’s clinical training focused on providing mental health services in low-fee clinics and hospitals to traditionally underserved communities in the Bronx, Brooklyn, and Nassau County.
Maisie graduated in 2020 from the University of Edinburgh with a BA in Sustainable Development and Social Anthropology. Her undergraduate dissertation explored psychedelics, ecological consciousness, and relational ontologies. She is currently pursuing an MA in Developmental Psychology at Teachers College, Columbia University. Her interests center around how our sense of self may emerge and crystallize over time, and how we may explore and design interventions to shift and expand it. At Fluence, Maisie assists in the production of program materials and written content. She lives in NYC and Woodstock, NY.
Dr. Alan Davis
Dr. Alan Davis is an Assistant Professor of Social Work at Ohio State University and Adjunct Assistant Professor in the Center for Psychedelic and Consciousness Research at Johns Hopkins University. Dr. Davis’s clinical experience includes working with people diagnosed with trauma-based psychological problems and includes providing evidenced-based treatments such as motivational interviewing, acceptance and commitment therapy, and psilocybin-assisted psychotherapy. His research interests focus on helping those suffering with substance use and mental health problems and developing ways to conceptualize substance use and mental health problems through a strengths-based approach. He recently completed a clinical trial of psilocybin therapy for depression and current trials exploring psychedelic treatment for patients with co-occurring alcohol use disorder and depression and patients with anorexia. He examines topics related to naturalistic psychedelic use among several populations including people of color who have experienced racial trauma, Spanish-speaking people, and people who use novel psychedelics such as 5-MeO-DMT.
Manager of Operations and Finance
Ashley is a Licensed Massage Therapist and yoga teacher based in Portland, Oregon. For the past decade, she has focused on the medicine of mindfulness and movement. She currently teaches meditation, yoga nidra, yoga asana and assists her teacher Michele Loew in Vajrayana Buddhism trainings. Ashley has a private massage practice based in Portland. Her approach to bodywork is influenced by the technicality of myofascial and structural work as well as her studies in yoga, regularly incorporating different breathing awarenesses in the practice.
Jayne Gumpel, LCSW
Jayne is a licensed Clinical Social Worker with 30 years of clinical experience and training. Non ordinary states of consciousness often offer clients extraordinary learning opportunities for deep and sustainable change, and Jayne offers support and integration guidance for those who are attracted to healing modalities such as plant medicine, ketamine, body centered therapies and breathwork. She is a MBSR teacher, experienced meditator, and co-founder of Access Mindfulness, a non-profit dedicated to bringing mindfulness to schools. She offers clinical services remotely and in person Midtown East, NYC and Woodstock, New York.
David Gumpel, MA
Student Support & Technology and Assistant Trainer
David Gumpel is an Integral Master Coach and a qualified teacher of Mindfulness-Based Stress Reduction (MBSR) through UMASS medical school. David is the co-founder of Access Mindfulness and a study coordinator for the MAPS sponsored MDMA-Assisted Therapy for the treatment of post-traumatic stress disorder study in NYC. As a coach, David teaches mindfulness to clients in private practice and to groups in corporate settings. At Fluence, David provides Mentoring and teaches MBSR courses for Certificate Program Participants. Find him online at ebcpathways.com.
Dr. Jeffrey Guss
Lead Trainer and Psychoanalytic Program Director
Jeffrey Guss, MD, is a psychiatrist, psychoanalyst, and researcher with specializations in psychoanalytic therapy, addictions and psychedelic therapy. He was Co-Principal Investigator and Director of Psychedelic Therapy Training for the NYU School of Medicine’s study on psilocybin-assisted psychotherapy in the treatment of cancer related existential distress, and is currently is a study therapist on studies of Psilocybin-Assisted treatment of Major Depressive Disorder and MDMA-Assisted Psychotherapy for PTSD. Dr. Guss is interested in the integration of psychedelic therapies with contemporary psychoanalytic theory and has published in Studies in Gender and Sexuality and Psychoanalysis, Culture and Society. He co-authored a paper on the influence of therapists’ first hand experience with psychedelics on psychedelic-assisted psychotherapy research and is an Instructor and Mentor with the California Institute of Integral Studies’ Center for Psychedelic Therapies. He maintains a private practice in New York City.
Aja Molinar, MA
Diversity Fund Manager and Assistant Trainer
Aja Molinar is a graduate student in psychology at the New School for Social Research, where she is a member of the Psychopathology Lab. Aja is also a member of the Portland Psychedelics Virtual Research Lab led by Dr. Jason Luoma and Dr. Brian Pilecki. She is interested in psychedelic science, in addition to research on boredom and depression. Within the Psychopathology Lab, she is also part of a team designing a protocol to measure clinical outcomes for ketamine-assisted psychotherapy. Aja has also assisted in writing a peer-reviewed article with Dr. Ingmar Gorman and Dr. Elizabeth Nielson on psychedelic harm reduction and integration.
Sarah Snider owns a bookkeeping and financial services firm in Kingston, New York. She works with radical clients in the Hudson Valley, specializing in nonprofit and worker coop accounting. Outside of work, she keeps busy biking, trail running, and working on her Catskills 3,500 Club hiking designation. Sarah has a Masters of Sociology + Cultural Studies from the London School of Economics, a degree in French Literature from the Sorbonne, a Bachelors of History from the American University of Paris, and studied herbalism and yoga in New York.
Donna Sorgen, LMHC, LPC
Interim Ketamine Certificate Program Director
Donna Sorgen, LMHC,LPC (she/her) is a psychotherapist with over 25 years experience working with adults, children, adolescents, couples and groups. She is the Director/Owner of the Woodstock Therapy Center, a collective of practitioners providing a variety of services to the community including Ketamine Assistant Psychotherapy (KAP), psychiatric services , psychotherapy and holistic modalities. Donna has spent her career working with diverse clients in multiple settings. Her current private practice includes KAP, Psychotherapy and Psychedelic integration therapy. Donna has completed training in MDMA-Assisted Psychotherapy for PTSD through the Multidisciplinary Association for Psychedelic Studies(MAPS). She was a sushi chef, caterer and enjoys the outdoors and gardening.
Dr. Kelan Thomas
Kelan is an Associate Professor and Board Certified Psychiatric Pharmacist with outpatient behavioral health practice sites in San Francisco and Oakland. His research interests include adverse reactions and drug interactions related to psychiatric medications and psychedelic-assisted therapy.